☆ 4.3 Article

Value of the risk of ovarian malignancy algorithm index in predicting the recurrence of epithelial ovarian cancer

BIOMARKERS IN MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Reproductive Biology

Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer

Yan Rong et al.

Summary: The study evaluated the clinical value of early clearance of HE4 and CA125 in predicting platinum sensitivity and prognosis in patients with ovarian cancer. The results showed that early clearance of HE4 and CA125 could predict platinum response and prognosis, aiding in predicting the risk of progression and relapse.

JOURNAL OF OVARIAN RESEARCH (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer

Minghai Zhang et al.

Summary: CA125, discovered approximately 40 years ago, is widely used in ovarian cancer screening but its reliability in early-stage diagnosis remains controversial. However, it has proven valuable in evaluating chemotherapy effectiveness and prognosis. Studies suggest CA125 plays a role in the occurrence and development of ovarian cancer, leading to increased focus on CA125-targeted treatment strategies for better anticancer therapy design.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Add to Collection

News Item Medicine, General & Internal

Screening for ovarian cancer is ruled out after trial found it did not reduce deaths

Nikki Nabavi

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Obstetrics & Gynecology

Prognostic significance of tumor laterality in advanced ovarian cancer

Yuki Yamada et al.

Summary: Incorporating tumor laterality into the FIGO staging system can improve the predictive performance of advanced ovarian cancer patients' prognosis.

OBSTETRICS & GYNECOLOGY SCIENCE (2021)

Add to Collection

Article Medicine, General & Internal

Correlation analysis and clinical significance of CA125, HE4, DDI, and FDP in type II epithelial ovarian cancer

Li Qiao et al.

MEDICINE (2020)

Add to Collection

Review Oncology

CA125 and Ovarian Cancer: A Comprehensive Review

Parsa Charkhchi et al.

CANCERS (2020)

Add to Collection

Review Medicine, General & Internal

Epithelial ovarian cancer

Stephanie Lheureux et al.

LANCET (2019)

Add to Collection

Review Reproductive Biology

Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review

Vincent Dochez et al.

JOURNAL OF OVARIAN RESEARCH (2019)

Add to Collection

Article Oncology

Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis

Ranliang Cui et al.

CANCER MANAGEMENT AND RESEARCH (2019)

Add to Collection

Review Oncology

Ovarian cancer relapse: From the latest scientific evidence to the best practice

Daniela Luvero et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)

Add to Collection

Article Cell Biology

Ovarian Cancer: A Heterogeneous Disease

Myriam Kossai et al.

PATHOBIOLOGY (2018)

Add to Collection

Article Oncology

Changes in the Management and Prognosis of Ovarian Cancer Due to the New FIGO and WHO Classifications A Case Series Observational Descriptive Study. Seven Years of Follow-up

Monica Gomes Ferreira et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)

Add to Collection

Review Oncology

The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review

Giuseppe Scaletta et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2017)

Add to Collection

Review Oncology

Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature

Stella Capriglione et al.

MEDICAL ONCOLOGY (2017)

Add to Collection

Article Oncology

Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients

Q. -L Li et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2017)

Add to Collection

Article Obstetrics & Gynecology

CA125 and HE4: Measurement Tools for Ovarian Cancer

Tingting Zhao et al.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2016)

Add to Collection

Article Oncology

HE4 combined with CA125: favorable screening tool for ovarian cancer

Nasrin Ghasemi et al.

MEDICAL ONCOLOGY (2014)

Add to Collection

Article Oncology

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

Richard G. Moore et al.

GYNECOLOGIC ONCOLOGY (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.